Merck Ethics Study In developing a drug to combat river blindness‚ pharmaceutical company Merck discovered an opportunity to treat millions of affected peoples around the world that probably would never see commercial use. The drug in development‚ ivermectin‚ was unaffordable to the primary victims of river blindness‚ Third World peoples. Thus‚ Dr. Vagelos‚ the head of research at the time‚ treaded upon a ethical quagmire; he could either choose to scrap the drug and its further research or
Premium Ethics Philosophy of life Person
of its products. Because of such high growth and rapid change‚ Apple must adopt the optimal corporate structure moving forward to maintain its competitive advantage. Due to the variety of features of the iPhone and other products‚ Apple can find synergy in similar features between different products and thus a matrix structure should be optimal. First‚ it is easy to see that a functional structure would not be efficient for Apple. The functional structure is designed for a firm with one or closely
Premium Apple Inc.
boot" page of this website‚ mergers between corporations sometimes are paid for with a combination of stock and cash‚ which provides a unique accounting challenge. The general tax rule is that you must pay capital gains tax on such a transaction‚ but only to the extent of "cash to boot" which is the amount of cash you actually received. (It’s technically called a Section 368 reorg.) In some cases‚ such as Fording Canadian and the Wyeth merger with Pfizer‚ the merger consideration is fully taxable--your
Premium Taxation in the United States Berkshire Hathaway Stock market
heart attacks f) Merck blamed naproxen for skewing the results against Vioxx 3) New England Journal of Medicine Omission g) Merck omits three heart attacks from article submission h) Inclusion of omitted data caused a significantly greater result 4) FDA Reaction i) Letter regarding downplay of risks j) Addition of warning label to Vioxx k) Additional study results 5) Approve Study l) Results with placebo group cause Merck to recall drug
Premium Coronary artery disease Aspirin Hypertension
1. How has Merck been able to achieve substantial returns to capital given the large costs and lengthy time to develop drugs? Merck had a 14% increase in sales between 1997 and 1998 and 22% increase in sales from 1998 – 1999‚ and a 13% annual increase in earnings over the same period. Merck’s business strategy consists of two parts: (1) developing and marketing new drugs through internal research‚ and (2) developing partnerships with smaller biotechnology companies. Since 1995‚ Merck had launched
Premium Expected value License Money
Analysis on Merck: Conflict and change Assessment: Merck is one of the biggest pharmaceutical companies in the world today. Although encountered with success‚ it still faces many problems today while trying to be the market leader competing against its competition. While being research and development driven company‚ Merck now has to go beyond R&D to stay competitive in the pharmaceutical industry. The main issue that seems to come
Premium Pharmaceutical industry Pharmacology
Motives and Effects of Mergers and Acquisitions by JUANJUAN WANG September 2007 A dissertation presented in part consideration for the degree of MA in Finance and Investment Acknowledgements I would like to take this opportunity to express my sincere appreciation to all those people who helped me complete this dissertation. Firstly‚ I do appreciate my supervisor Ms. Lynda Taylor’s assistance. She gave me valuable feedback and guidance throughout this dissertation. In addition‚ I
Premium Mergers and acquisitions Stock market
including Bayer AG and Novartis are exploring a deal for Merck & Co Inc’s consumer healthcare business‚ as they seek to gain scale in a fragmented industry‚ according to several people familiar with the matter. Reckitt Benckiser Group PLC and Procter & Gamble Co are also among the parties that have held discussions with Merck about buying the unit‚ best known for Coppertone sunscreen and Claritin allergy medicine‚ the sources said this week. The Merck business‚ which also includes Dr. Scholl’s foot
Premium Pharmacology Marketing Pharmacy
TO: Dr. Roy Vagelos‚ Chairman and CEO Merck Corporation. January‚ 1991. The decision to move forward with the program to donate the new drug Mectizan on a large scale to the affected population in the Third World needs to be systematically analyzed. There are two especially important angles from which this decision needs to be considered. The first concern that needs to be taken into account is that of the stockholders and investors in this company‚ whose interests you are ultimately charged with
Premium Medicine Pharmacology Pharmacy
23: Mergers and Other Forms of Corporate Restructuring After studying Chapter 23‚ you should be able to: Chapter 23 Explain why a company might decide to engage in corporate restructuring. Understand and calculate the impact on earnings and on market value of companies involved in mergers. Describe what benefits‚ if any‚ accrue to acquiring company shareholders and to selling company shareholders. Analyze a proposed merger as a capital budgeting problem. Describe the merger process
Premium Corporate finance Fundamental analysis Mergers and acquisitions